Spectral Medical Inc. (EDTXF)
USD 0.57
(-3.03%)
USD 0.57
(-3.03%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 8.56 Million CAD | 28.83% |
| 2022 | 6.64 Million CAD | 1041.75% |
| 2021 | 582 Thousand CAD | -12.74% |
| 2020 | 667 Thousand CAD | -10.35% |
| 2019 | 744 Thousand CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | -100.0% |
| 2009 | 2.33 Million CAD | 7.55% |
| 2008 | 2.17 Million CAD | 8.17% |
| 2007 | 2 Million CAD | 8.95% |
| 2006 | 1.84 Million CAD | -78.75% |
| 2005 | 8.67 Million CAD | 10.73% |
| 2004 | 7.83 Million CAD | 0.95% |
| 2003 | 7.75 Million CAD | 33.65% |
| 2002 | 5.8 Million CAD | 32.15% |
| 2001 | 4.39 Million CAD | 9.8% |
| 2000 | 4 Million CAD | 81.82% |
| 1999 | 2.2 Million CAD | 450.0% |
| 1998 | 400 Thousand CAD | -50.0% |
| 1997 | 800 Thousand CAD | 0.0% |
| 1996 | 800 Thousand CAD | 300.0% |
| 1995 | 200 Thousand CAD | 0.0% |
| 1994 | 200 Thousand CAD | 0.0% |
| 1993 | 200 Thousand CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 9.26 Million CAD | 8.19% |
| 2024 Q2 | 13.05 Million CAD | 40.92% |
| 2023 Q3 | 12.28 Million CAD | 88.71% |
| 2023 Q2 | 6.51 Million CAD | -1.88% |
| 2023 Q4 | 8.56 Million CAD | -30.32% |
| 2023 FY | 8.56 Million CAD | 28.83% |
| 2023 Q1 | 6.63 Million CAD | -0.14% |
| 2022 Q4 | 6.64 Million CAD | 1195.32% |
| 2022 Q1 | 560 Thousand CAD | -3.78% |
| 2022 Q2 | 537 Thousand CAD | -4.11% |
| 2022 Q3 | 513 Thousand CAD | -4.47% |
| 2022 FY | 6.64 Million CAD | 1041.75% |
| 2021 Q4 | 582 Thousand CAD | -3.64% |
| 2021 Q1 | 646 Thousand CAD | -3.15% |
| 2021 Q2 | 625 Thousand CAD | -3.25% |
| 2021 Q3 | 604 Thousand CAD | -3.36% |
| 2021 FY | 582 Thousand CAD | -12.74% |
| 2020 Q2 | 707 Thousand CAD | -2.48% |
| 2020 Q3 | 688 Thousand CAD | -2.69% |
| 2020 FY | 667 Thousand CAD | -10.35% |
| 2020 Q1 | 725 Thousand CAD | -2.55% |
| 2020 Q4 | 667 Thousand CAD | -3.05% |
| 2019 Q1 | 796 Thousand CAD | 0.0% |
| 2019 Q3 | 762 Thousand CAD | -2.31% |
| 2019 Q4 | 744 Thousand CAD | -2.36% |
| 2019 FY | 744 Thousand CAD | 0.0% |
| 2019 Q2 | 780 Thousand CAD | -2.01% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2010 Q1 | 1.27 Million CAD | -45.59% |
| 2010 FY | - CAD | -100.0% |
| 2010 Q4 | - CAD | -100.0% |
| 2010 Q2 | 1.29 Million CAD | 1.89% |
| 2010 Q3 | 1.31 Million CAD | 1.85% |
| 2009 Q4 | 2.33 Million CAD | 0.0% |
| 2009 Q3 | - CAD | -100.0% |
| 2009 FY | 2.33 Million CAD | 7.55% |
| 2009 Q2 | 2.25 Million CAD | -13.24% |
| 2009 Q1 | 2.59 Million CAD | 19.61% |
| 2008 Q3 | 2.13 Million CAD | -6.74% |
| 2008 Q4 | 2.17 Million CAD | 1.92% |
| 2008 FY | 2.17 Million CAD | 8.17% |
| 2008 Q2 | 2.28 Million CAD | 11.52% |
| 2008 Q1 | 2.04 Million CAD | 2.04% |
| 2007 Q2 | 1.96 Million CAD | 4.03% |
| 2007 Q4 | 2 Million CAD | -13.26% |
| 2007 Q1 | 1.88 Million CAD | 0.0% |
| 2007 FY | 2 Million CAD | 8.95% |
| 2007 Q3 | 2.31 Million CAD | 18.05% |
| 2006 FY | 1.84 Million CAD | -78.75% |
| 2006 Q3 | 1.87 Million CAD | 2.01% |
| 2006 Q2 | 1.84 Million CAD | -80.83% |
| 2006 Q1 | 9.59 Million CAD | -6.11% |
| 2005 FY | 8.67 Million CAD | 10.73% |
| 2005 Q4 | 10.22 Million CAD | 7.62% |
| 2005 Q1 | 8.67 Million CAD | 6.11% |
| 2005 Q2 | 9.17 Million CAD | 5.84% |
| 2005 Q3 | 9.49 Million CAD | 3.49% |
| 2004 Q3 | 8.42 Million CAD | 0.37% |
| 2004 Q2 | 8.38 Million CAD | 7.13% |
| 2004 Q4 | 8.17 Million CAD | -2.95% |
| 2004 FY | 7.83 Million CAD | 0.95% |
| 2004 Q1 | 7.83 Million CAD | -0.15% |
| 2003 Q1 | 7.75 Million CAD | 26.96% |
| 2003 FY | 7.75 Million CAD | 33.65% |
| 2003 Q4 | 7.84 Million CAD | 463.84% |
| 2003 Q3 | 1.39 Million CAD | -79.5% |
| 2003 Q2 | 6.78 Million CAD | -12.5% |
| 2002 Q4 | 6.11 Million CAD | -33.8% |
| 2002 Q2 | 5.55 Million CAD | -4.22% |
| 2002 Q1 | 5.8 Million CAD | 0.24% |
| 2002 FY | 5.8 Million CAD | 32.15% |
| 2002 Q3 | 9.22 Million CAD | 66.02% |
| 2001 Q2 | 5.58 Million CAD | 27.16% |
| 2001 Q1 | 4.39 Million CAD | 5.73% |
| 2001 Q3 | 5.68 Million CAD | 1.72% |
| 2001 Q4 | 5.79 Million CAD | 1.92% |
| 2001 FY | 4.39 Million CAD | 9.8% |
| 2000 Q3 | 4.12 Million CAD | 0.61% |
| 2000 FY | 4 Million CAD | 81.82% |
| 2000 Q2 | 4.1 Million CAD | 2.5% |
| 2000 Q4 | 4.15 Million CAD | 0.7% |
| 2000 Q1 | 4 Million CAD | 33.33% |
| 1999 Q1 | 2.2 Million CAD | -24.14% |
| 1999 Q4 | 3 Million CAD | 20.0% |
| 1999 FY | 2.2 Million CAD | 450.0% |
| 1999 Q3 | 2.5 Million CAD | 25.0% |
| 1999 Q2 | 2 Million CAD | -9.09% |
| 1998 Q3 | 2.1 Million CAD | 600.0% |
| 1998 Q2 | 300 Thousand CAD | -25.0% |
| 1998 FY | 400 Thousand CAD | -50.0% |
| 1998 Q4 | 2.9 Million CAD | 38.1% |
| 1998 Q1 | 400 Thousand CAD | -20.0% |
| 1997 Q3 | 600 Thousand CAD | -14.29% |
| 1997 Q4 | 500 Thousand CAD | -16.67% |
| 1997 Q1 | 800 Thousand CAD | 0.0% |
| 1997 FY | 800 Thousand CAD | 0.0% |
| 1997 Q2 | 700 Thousand CAD | -12.5% |
| 1996 Q2 | 900 Thousand CAD | 12.5% |
| 1996 Q3 | 700 Thousand CAD | -22.22% |
| 1996 FY | 800 Thousand CAD | 300.0% |
| 1996 Q1 | 800 Thousand CAD | 14.29% |
| 1996 Q4 | 800 Thousand CAD | 14.29% |
| 1995 Q2 | 200 Thousand CAD | 0.0% |
| 1995 Q4 | 700 Thousand CAD | 250.0% |
| 1995 FY | 200 Thousand CAD | 0.0% |
| 1995 Q1 | 200 Thousand CAD | 100.0% |
| 1995 Q3 | 200 Thousand CAD | 0.0% |
| 1994 Q2 | 200 Thousand CAD | 0.0% |
| 1994 Q1 | 200 Thousand CAD | 0.0% |
| 1994 FY | 200 Thousand CAD | 0.0% |
| 1994 Q4 | 100 Thousand CAD | -50.0% |
| 1994 Q3 | 200 Thousand CAD | 0.0% |
| 1993 FY | 200 Thousand CAD | 0.0% |
| 1993 Q1 | 200 Thousand CAD | 56.61% |
| 1992 Q4 | 127.7 Thousand CAD | 2.34% |
| 1992 Q2 | 239.23 Thousand CAD | 0.0% |
| 1992 Q3 | 124.78 Thousand CAD | -47.84% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -282.188% |
| Arrayit Corporation | 1.07 Million USD | -694.033% |
| Atlantic International Corp. | 2.93 Million USD | -192.136% |
| Biocept, Inc. | 12.1 Million USD | 29.301% |
| Bioqual, Inc. | 3.58 Million USD | -138.668% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -11689.738% |
| DermTech, Inc. | 54.39 Million USD | 84.261% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 98.186% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -77.102% |
| iMD Companies, Inc. | 1.12 Million USD | -664.273% |
| IDenta Corp. | 789.14 Thousand USD | -984.844% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 23.508% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -19425.602% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | -6.415% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -123.765% |
| NovelStem International Corp. | 3.57 Million USD | -139.495% |
| Optigenex Inc. | 8.94 Million USD | 4.247% |
| PharmChem, Inc. | 77.35 Thousand USD | -10967.444% |
| Proteome Sciences plc | 17.15 Million USD | 50.092% |
| Response Genetics, Inc | 6.37 Million USD | -34.332% |
| Rennova Health, Inc. | 15.32 Million USD | 44.153% |
| RushNet, Inc. | 4.82 Million USD | -77.5% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -4035.07% |
| Stella Diagnostics Inc. | 6.2 Million USD | -38.065% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -375.589% |
| Todos Medical Ltd. | 38.34 Million USD | 77.675% |